Balestrieri ML, Rizzo MR, Barbieri M, et al
Whether tirzepatide specifically, with its dual GIP/GLP-1 mechanism and greater metabolic efficacy, confers similar or greater benefit remains unclear
Weight gain: Since Ozempic helps control hunger and promotes satiety, stopping the medication might increase calorie intake if not appropriately managed
A growing number of observations reveal that tumors can utilize a wide range of substrates to sustain cell survival and proliferation
When combined with GLP-1's appetite suppressive effects, the result is weight loss achieved through both reduced caloric intake and improved energy expenditurea more sustainable metabolic profile than appetite suppression alone
How long do I need to stay in the hospital after ESG